Delivery Order SPE2DR25D2001-SPE2DR26FBFW2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count) valued at $3,874.06 under a firm fixed-price contract. The award was issued on December 10, 2025, with an ultimate completion date of January 2, 2026. This non-set-aside delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle with the Defense Logistics Agency, with performance to occur at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,028.36 delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 MG capsules (30-count units) on August 25, 2025, with completion expected by September 16, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 MG capsules (30-count packaging) with an ultimate completion date of August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of INGREZZA 80 MG capsules (30-count units) under a firm fixed-price contract with a ceiling value of $8,055.40 and an ultimate completion date of October 17, 2025. This non-set-aside, competitively awarded delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The contractor will perform under this order at its corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a $8,535.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for INGREZZA 60 mg capsules (30-count) with a completion date of December 2, 2025. This non-set-aside delivery order represents a competitively awarded pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $4,267.66 to AmerisourceBergen Drug Corp for the supply of INGREZZA 60 mg capsules (30-count units) on December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract's ultimate completion date is December 31, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of INGREZZA 80 mg capsules (30-count units) valued at $4,027.70. The contract utilizes firm fixed price terms with an ultimate completion date of October 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,748.14 on November 4, 2025, for the supply of INGREZZA 40 MG capsules (30-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBFW2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of INGREZZA 80 mg capsules (30-count units) valued at $4,244.58 under a firm fixed price contract. The award was made on December 10, 2025, with an ultimate completion date of January 2, 2026. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product is a medication used in the treatment of neurological conditions and represents a routine pharmaceutical procurement through the agency's medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's contract performance supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities with flexible access to a broad range of pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 12/9/25 |